Show
Sort by
-
The HBP1 tumour suppressor is a negative epigenetic regulator of MYCN-driven neuroblastoma through interaction with the PRC2 complex
-
The TBX2 super-enhancer marked transcription factor on 17q is overexpressed in neuroblastoma and infers poor prognosis
-
Targeting MYCN-driven transcription by BET-bromodomain inhibition
-
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
-
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
-
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
-
- Journal Article
- A1
- open access
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
-
Mutational dynamics between primary and relapse neuroblastomas
-
- Journal Article
- A1
- open access
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes
-
- Journal Article
- A1
- open access
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma